Show Summary Details
Page of

Polyarteritis nodosa: Clinical characteristics, outcome, and treatment 

Polyarteritis nodosa: Clinical characteristics, outcome, and treatment
Chapter:
Polyarteritis nodosa: Clinical characteristics, outcome, and treatment
Author(s):

Loïc Guillevin

DOI:
10.1093/med/9780199579655.003.0075
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 03 April 2020

Polyarteritis nodosa (PAN) was the first vasculitis to be described by Küssmaul and Maier. For many years what are now known to be distinct vasculitides were then considered together under the term PAN. The last to be separated from PAN were Churg–Strauss syndrome, a vasculitis occurring in asthmatic patients, and microscopic polyangiitis (MPA), individualized from PAN by Wohlwill then redefined by Davson et al. Today, PAN is a well-defined vasculitis that affects medium sized vessels. Considering PAN aetiologies, primary and secondary forms can also be discerned, as PAN can be the consequence of hepatitis B virus (HBV) infection, and sometimes of other aetiological agents. In this chapter, we review the main characteristics of PAN, its outcome and treatment. PAN histology and pathogenesis have been extensively detailed in other chapters of this book.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.